RecruitingNCT04721717
AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
Sponsor
University of Alabama at Birmingham
Enrollment
160 participants
Start Date
Sep 1, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The UAB Institute for Arts In Medicine (AIM) is currently implementing an expressive emotional writing pilot project for adults with paralysis caused by neurological conditions such as traumatic head or spinal cord injury.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study offers a writing-based workshop for people living with paralysis. Through expressive writing, participants can process their experiences and explore emotional healing. It is also open to caregivers of people with ALS.
**You may be eligible if:**
- You are 18 or older and living with limb paralysis in the community
- Your paralysis resulted from a traumatic injury or neurological disease (such as spinal cord injury, stroke, MS, Parkinson's, ALS, or Guillain-Barré syndrome) that occurred after childhood
- You are a caregiver of someone with ALS
- You can communicate verbally or in writing
**You may NOT be eligible if:**
- You have known patterns of harmful behavior or active psychotic symptoms (such as hallucinations or delusions)
- Your paralysis has been present since birth (e.g., spina bifida or cerebral palsy)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04721717
Related Trials
Ultra-high-caloric, Fatty Diet in ALS
NCT0628007923 locations
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
NCT027842101 location
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT000012481 location
Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?
NCT053577811 location
Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
NCT058494671 location